Immunization, measles second dose (% of children by the nationally) in Norway
Norway: Immunization, measles second dose (% of children by the nationally) was 94.0% in 2024. ▬ Flat
Immunization, measles second dose in Norway, 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
Norway recorded 94.0% for immunization, measles second dose in 2024.
Compared with earlier readings it is up 2.2% over ten years.
Over the whole period, immunization, measles second dose in Norway peaked at 97.0% in 2010 and was at its lowest, 89.0%, in 2003.
Norway ranks 40th of 178 countries on this measure, in the top quarter.
Immunization, measles second dose (% of children by the nationally) in Norway, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2000 | 90.0% | — |
| 2001 | 90.0% | +0.0% |
| 2002 | 90.0% | +0.0% |
| 2003 | 89.0% | -1.1% |
| 2004 | 90.0% | +1.1% |
| 2005 | 91.0% | +1.1% |
| 2006 | 91.0% | +0.0% |
| 2007 | 93.0% | +2.2% |
| 2008 | 95.0% | +2.2% |
| 2009 | 96.0% | +1.1% |
| 2010 | 97.0% | +1.0% |
| 2011 | 94.0% | -3.1% |
| 2012 | 91.0% | -3.2% |
| 2013 | 91.0% | +0.0% |
| 2014 | 92.0% | +1.1% |
| 2015 | 91.0% | -1.1% |
| 2016 | 91.0% | +0.0% |
| 2017 | 91.0% | +0.0% |
| 2018 | 93.0% | +2.2% |
| 2019 | 95.0% | +2.2% |
| 2020 | 95.0% | +0.0% |
| 2021 | 95.0% | +0.0% |
| 2022 | 94.0% | -1.1% |
| 2023 | 94.0% | +0.0% |
| 2024 | 94.0% | +0.0% |
Norway compared with similar countries
- Norway's 94.0% is above the median for high income countries, which is 92.0%, 1.0× the median. (63 countries reporting)
- Norway's 94.0% is above the median for Europe & Central Asia, which is 92.0%, 1.0× the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 91.5% | 89.0% | 96.0% | 10 |
| 2010s | 92.6% | 91.0% | 97.0% | 10 |
| 2020s | 94.4% | 94.0% | 95.0% | 5 |
Countries ranked near Norway
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Un projection of annual infant deaths 12 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.217 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0238 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0617 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0251 units per person (2025)
Frequently asked questions
- What is immunization, measles second dose in Norway?
- Immunization, measles second dose in Norway was 94.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Norway?
- The highest recorded value was 97.0% in 2010.
- What is the lowest immunization, measles second dose recorded in Norway?
- The lowest recorded value was 89.0% in 2003.
- How does Norway rank for immunization, measles second dose?
- Norway ranks 40th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Norway?
- Over the last ten years it is up 2.2%. The long-run trend across the full record is flat.
- Where does this Norway data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.